<DOC>
	<DOCNO>NCT00897364</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue smoker non-smokers laboratory may help doctor identify learn biomarkers related cancer . PURPOSE : This phase II study look biomarkers nose , throat , lung tissue smoker non-smokers .</brief_summary>
	<brief_title>Biomarkers Nose , Throat , Lung Tissue Smokers Non-Smokers</brief_title>
	<detailed_description>OBJECTIVES : Primary - Define molecular biochemical profile airway epithelium smoker disease , smoker airflow obstruction abnormal sputum cytology , non-smokers . Secondary - Assess occurrence abnormality non-smokers , smoker disease , smoker various grade dysplasia , smoker lung cancer . OUTLINE : Patients stratify accord smoking status ( smoker v non-smoker ) disease ( disease v airflow obstruction abnormal sputum cytology vs various grade dysplasia vs lung cancer ) . Biological sample collect analyzed future research study . PROJECTED ACCRUAL : A total 78 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>1 . Adults &gt; 45 year age , age match previously enrol cohort current exsmokers airflow obstruction moderate atypia sputum cytology , include follow group . 2 . Nonsmoking ( less 100 cigarette per lifetime ) control &gt; 50 year age , age match previously enrol cohort airflow obstruction ( FEV1 &lt; 75 % predict FEV1/FVC &lt; 75 % ) moderate atypia sputum cytology . 3 . Current smoker &gt; 30 pack year , airflow obstruction ( FEV1 &gt; 90 % predict ) lung cancer , &gt; 50 year age , age match previously enrol cohort airflow obstruction moderate atypia sputum cytology . 4 . No prior history head neck bronchogenic carcinoma . 5 . Patients must fully inform investigational nature study must sign informed consent accordance institutional FDA guideline . 1 . Clinically apparent bleeding diathesis . 2 . Cardiac dysrhythmia potentially lifethreatening , ventricular tachycardia , multifocal premature ventricular contraction supraventricular tachycardia rapid ventricular response . Wellcontrolled atrial fibrillation rare ( &lt; 2/minute ) premature ventricular contraction exclusionary . 3 . Hypoxemia ( less 90 % saturation supplemental oxygen ) bronchoscopy . 4 . Evidence clinically active coronary artery disease , include myocardial infarction within 6 week , chest pain , poorly control congestive heart failure , serious medical condition would preclude patient undergoing bronchoscopy . 5 . Acute bronchitis pneumonia within 8 week . 6 . Inability give inform consent . 7 . Current smoker airflow obstruction may history cough two time /week .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>squamous lung dysplasia</keyword>
</DOC>